Navigation Links
Largest ever study of genetics of common disease just got bigger
Date:4/13/2008

DNA samples from 120,000 people are to be analysed in a 30 million follow up to last year's Wellcome Trust Case Control Consortium (WTCCC), the largest ever study of the genetics behind common diseases. The seven-fold increase in the number of samples to be analysed will allow researchers to look at a 25 diseases as well as studying the genetics of learning in children and individuals' responses to statins.

Funded by the Wellcome Trust, this new series of genome-wide association studies will be one of the most ambitious initiatives ever undertaken, bringing together leading research groups from at least 60 institutions internationally (including over 20 from the UK). Over the next two years, working in collaboration with the WTCCC or independently, the research teams are expected to analyse as many as 120 billion pieces of genetic data in the search for the genes underlying diseases such as multiple sclerosis, schizophrenia and asthma.

Researchers will examine between 500,000 and 1 million variants (SNPs) per sample as well as a comprehensive set of copy number variants (CNVs). Both SNPs and CNVs are responsible of the individual variation in our genomes.

"We have now entered a new era of large-scale genetics unthinkable even a few years ago," says Professor Peter Donnelly from the University of Oxford, who will chair the consortium. "Breakthroughs in our understanding of the human genome and rapid advances in sequencing technology mean that we are able to do very powerful analysis much faster and on a vastly bigger scale than ever before."

When the results of the WTCCC were announced in 2007, it was seen as a major breakthrough for medical science and was selected as one of the scientific highlights of the year by a number of the most prestigious scientific journals, including Nature and The Lancet. It identified a number of new genes and regions of the human genome which increase peoples susceptibility to or protect them fr
'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Largest study to investigate risk factors of autism to begin enrolling families
2. Single-largest biodiversity survey says primary rainforest is irreplaceable
3. Worlds largest investor coalition seeks further disclosure on climate change and shareholder value
4. Worlds largest marine protected area created in Pacific Ocean
5. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. Study begins to reveal clues to the cause and progression of sepsis
8. Clones on task serve greater good, evolutionary study shows
9. New study warns limited carbon market puts 20 percent of tropical forest at risk
10. New study examines how rearing environment can alter navigation
11. Study links cat disease to flame retardants in furniture and to pet food

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , REDWOOD CITY, Calif., Dec. 2 /PRNews...rint identity and authentication solutions, today ...del of its DigitalPersona biometric fingerprint te...gitalPersona U.are.U® 4500HD offering allows ...kly identify users so that specific transactions c...
(Date:12/2/2009)..., , Before one of your muscles can twitch, before... nerve, a tiny floodgate of sortscalled an ion cha... organs to let in the chemical signals that spur t...nstitute of Standards and Technology (NIST) has al...e surface membrane for the first time, potentially...
(Date:12/2/2009)..., New York, NY, December 2, 2009 Commonly prescr...ment of asthma in pregnant women as well as pre-te...trum disorders, psychiatric pathology, cognitive p...ren, according to a new study published in the Dec...trics & Gynecology . , Beta 2 adrenergic agonist...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Nervy research: Researchers take initial look at ion channels in a model system 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2IH Systems RIVA Top Pick for Directors of Pharmacy 57370 1IH Systems RIVA Top Pick for Directors of Pharmacy 57370 2HMS Awarded Third Party Liability Services Contract by Minnesota 57366 1Dr Drew and Drug Czar Host Online Chat 57362 1
...009) The Michael & Susan Dell Center for Advancem...chool of Public Health Austin Regional Campus will...eship in Child Health at 1:30 p.m. Thursday, April...e Center Amphitheater in Austin. , Obesity expe...biostatistics and epidemiology at the University o...
...astatic prostate cancer has shown considerable pro...hose disease has become resistant to current drugs...gues at several other institutions, including Memo... new drug to treat a particularly lethal form of t... cancer, or CRPC. Also referred to as hormone-refr...
...9, 2009 -- Four experts in soil carbon research, f...tunity farmers and foresters have to manage soil c...ate in voluntary markets. Agricultural and forest ...50 million metric tons of carbon dioxide (CO 2 ) e... gas emissions. , The briefing, "Down to Earth Ca...
Other Biology News:Annual Michael & Susan Dell lectureship in child health 2New drug shows promise in treating drug-resistant prostate cancer 2New drug shows promise in treating drug-resistant prostate cancer 3New drug shows promise in treating drug-resistant prostate cancer 4Down to Earth carbon science: Briefing April 15 in DC 2
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte L... oral JAK2 inhibitor, SB1518, at The American Soci...on in New Orleans. ,, Data will be presented on...tion trial of SB1518 detailing its safety, tolerab...profile in dose levels ranging from 100 to 600 mg....
(Date:12/2/2009)..., NANJING, China, Dec. 2 /PRNewswire-Asia/ -- ...mpany") (NYSE: SCR ), a leading pharmaceutical c...ing, and marketing of branded,generic and propriet... 105 of,its drugs have been included in China,s Na... issued by China,s Ministry of Human Resources and...
(Date:12/2/2009)..., SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The wo...are in turmoil and uncertainty is part of many,bus...ma industry has been,relatively immune to the econ...tion. , During the midst of the difficult... & Johnson inaugurated an R&D center in Sh...
(Date:12/2/2009)...HOBOKEN, N.J., Dec. 2 According to...5 percent of Americans diagnosed with diabetes alr...betic retinopathy, damage to the retina caused by ... in people with diabetes and is one of the most fe...rcent of all patients who,ve had diabetes for 10 y...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...fications, thereby providing scientists with a too...duction to drug discovery. However, this sophistic...ing the threat of engineered pathogens. New resear...ome Biology shows that computational tools could b...ally engineered bacteria in environmental samples....
...ISE, Fla., March 17 Bioheart, Inc.,(Nasdaq: BHRT...elop,autologous (patient-derived) cell therapies a...heart damage, today announced that company founder...transition from Executive,Chairman and become Chai...,serves as the company,s Chief Technology Officer ...
...rch 19 at 10:00 AM EDT, CEDAR KNOLLS, N.J., March... today announced its financial results for,the fou...isphere will host a conference call to discuss fou...ch 19, 2008. A live webcast of the conference,call...: http://www.emisphere.com .,The live conference ...
Other Biology Technology:On the trail of rogue genetically modified pathogens 2Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors 2Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors 3Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors 4Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 2Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 3Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 4Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 5Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 6Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 7Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 8
Mouse Anti-PDK1 Docking Motif, phospho (Ser / Thr) Monoclonal Antibody, Unconjugated, Clone 18A2 from Cell Signaling Technology
Mouse Anti-Human Clusterin alpha chain Monoclonal Antibody, Unconjugated, Clone 41D from Upstate
Rabbit Anti-Human MT3-MMP Membrane-Type Metalloproteinase-3, propeptide domain, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-Methionine Aminopeptidase 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: